Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Steinbach
W J
WJ
Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Box 3499, Durham, NC, USA. stein022@mc.duke.edu
Schell
W A
WA
Miller
J L
JL
Perfect
J R
JR
Martin
P L
PL
D000935:Antifungal Agents / Q000627:therapeutic use; D000077336:Caspofungin; D002648:Child; D054714:Echinocandins; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D008297:Male; D003904:Mitosporic Fungi; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology*; D009894:Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D010455:Peptides / Q000627:therapeutic use; D010456:Peptides, Cyclic; D011743:Pyrimidines / Q000627:therapeutic use; D033581:Stem Cell Transplantation; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000077336:Caspofungin; D065819:Voriconazole